Andersen syndrome: The newest variant of the hereditary-familial long QT syndrome

Annals of Noninvasive Electrocardiology

Volumn 9, Issue 2, 2004, Pages 175-179

  Riera, Andrés Ricardo Pérez ^d   Ferreira, Celso ^a   Dubner, Sérgio J ^b   Schapachnik, Edgardo ^c  

^a ABC Univ Fund Santo André   (Brazil)

^b Arrhythmias and Electrophysiology Service   (Argentina)

^c HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^d NONE

Author keywords

Andersen syndrome; Channelopathies; Long QT; Periodic paralysis

Indexed keywords

ION CHANNEL;

ANDERSEN SYNDROME; AUTOSOMAL DOMINANT INHERITANCE; CHANNEL GATING; CHROMOSOME 17; CLINICAL FEATURE; DISEASE TRANSMISSION; GENETIC CODE; GENETIC DISORDER; HEART MUSCLE FIBER MEMBRANE; HUMAN; LONG QT SYNDROME; PRIORITY JOURNAL; REVIEW; SARCOLEMMA;

ACTION POTENTIALS; CARBONIC ANHYDRASE INHIBITORS; ELECTROCARDIOGRAPHY; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN STORAGE DISEASE TYPE IV; HEART CONDUCTION SYSTEM; HUMANS; LONG QT SYNDROME; PARALYSES, FAMILIAL PERIODIC; POTASSIUM CHANNELS;

EID: 2342556622     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.2004.92552.x     Document Type: Review

References (12)

1. Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001;105:511-519.
2. Jongsma HJ, Wilders R. Channelopathies: Kir2.1 mutations jeopardize many cell functions. Curr Biol 2001;11(18):R747-R750.
3. Andersen ED, Krasilnikoff PA, Overvad H. Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand 1971;60:559-564.
4. Nakamagoe K, Fujita T, Ohkoshi N, et al. A case of potassium-sensitive periodic paralysis with cardiac dysrhythmia. Rinsho Shinkeigaku 1997;37:239-242.
5. Lucet V, Lupoglazoff JM, Fontaine B. Andersen syndrome, ventricular arrhythmias and channelopathy (A case report). Arch Pediatr 2002;9:1256-1259.
6. Sansone V, Griggs RC, Meola G, et al. Andersen's syndrome: A distinct periodic paralysis. Ann Neurol 1997;42:305-312.
7. Andelfinger G, Tapper AR, Welch RC, et al. KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes. Am J Hum Genet 2002;71:663-668.
8. Schwalbe RA, Rudin A, Xia SL, et al. Site-directed glycosylation tagging of functional Kir2.1 reveals that the putative pore-forming segment is extracellular. J Biol Chem 2002;277(27):24382-24389.
9. Ai T, Fujiwara Y, Tsuji K, et al. Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia. Circulation 2002;105(22):2592-2594.
10. Preisig-Muller R, Schlichthorl G, Goerge T, et al. Heteromerization of Kir2.x potassium channels contributes to the phenotype of Andersen's syndrome. Proc Natl Acad Sci USA 2002;99:7774-7779.
11. Tristani-Firouzi M, Jensen JL, Donaldson MR, et al. Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome). J Clin Invest 2002;110:381-388.
12. Katz JS, Wolfe GI, Iannaccone S, et al. The exercise test in Andersen Syndrome. Arch Neurol 1999;56:352-356.